FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100488932> ?p ?o ?g. }

• W3100488932 endingPage "184" @default.
• W3100488932 startingPage "177" @default.
• W3100488932 abstract "Prognostic factors for endocervical adernocarcinomas are well known, but little is known about prognostic biomarkers influencing outcome for the newly defined International Federation of Gynecology and Obstetrics (FIGO) 2018 IB sub-stages. The aim of this study was to identify prognostic biomarkers influencing recurrence-free and overall survival for FIGO 2018 stage IB cervical adenocarcinoma sub-types. We sought to identify these factors using a large international multi-institutional series of cases.Stage IB endocervical adenocarcinomas were retrospectively collected from nine international institutions; full slide sets (n=464) were used to assign prognostic biomarkers. Inclusion criteria were the following: FIGO stage IB endocervical adenocarcinomas with follow-up in which all paraffin blocks/glass slides were available for review and/or additional studies and the patient was surgically treated from 1985 to 2019. The types of specimens included in the study were conizations, trachelectomies, and simple/radical hysterectomies with or without lymph node samples. We excluded in situ carcinomas, squamous cell carcinomas, adenosquamous carcinomas, tumors with a neuroendocrine component, carcinosarcomas, and any tumor showing clinical, macroscopic, or microscopic features suggesting a lower uterine segment, uterine corpus, or an adnexal primary origin. Tumors treated with neoadjuvant chemotherapy and/or radiation therapy were also excluded, as well as biopsies and loop electrosurgical excision procedures.Of 464 cases, 225 (48%) were stage IB1, 177 (38%) were stage IB2, and 62 (13%) were stage IB3. Five-year and 10-year recurrence-free survivals were statistically different among stage IB sub-types (p=0.005). Silva pattern of invasion was significant for recurrence-free survival at 5 and 10 years (p=0.04); overall survival and recurrence-free survival were higher in human papillomavirus (HPV)-associated cases (p=0.007 and p=0.001, respectively) and in cases without lymphovascular invasion (p=0.004 and p=0.00001, respectively). Factors that significantly influenced recurrence-free survival were HPV-independent status (p=0.05; HR 2.31; 95% CI 1.02 to 5.46), presence of lymphovascular invasion (p=0.011; HR 3.50; 95% CI 1.33 to 9.19), and presence of lymph node metastasis (p=0.016; HR 2.66; 95% CI 1.20 to 5.90).HPV status and the presence of lymphovascular invasion are prognosticators in stage IB endocervical adenocarcinoma sub-types. These parameters should be included in future sub-staging modifications of FIGO stage IB endocervical adenocarcinomas and in treatment strategies." @default.
• W3100488932 created "2020-11-23" @default.
• W3100488932 creator A5001959447 @default.
• W3100488932 creator A5002011120 @default.
• W3100488932 creator A5003962206 @default.
• W3100488932 creator A5013693581 @default.
• W3100488932 creator A5014189905 @default.
• W3100488932 creator A5014743938 @default.
• W3100488932 creator A5016164818 @default.
• W3100488932 creator A5016445492 @default.
• W3100488932 creator A5018811618 @default.
• W3100488932 creator A5019663026 @default.
• W3100488932 creator A5040765699 @default.
• W3100488932 creator A5052359409 @default.
• W3100488932 creator A5053542215 @default.
• W3100488932 creator A5055502131 @default.
• W3100488932 creator A5064259361 @default.
• W3100488932 creator A5086380204 @default.
• W3100488932 date "2020-11-11" @default.
• W3100488932 modified "2023-10-14" @default.
• W3100488932 title "FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers" @default.
• W3100488932 cites W2037396048 @default.
• W3100488932 cites W2405709993 @default.
• W3100488932 cites W2769841906 @default.
• W3100488932 cites W2805594491 @default.
• W3100488932 cites W2911389352 @default.
• W3100488932 cites W2993250673 @default.
• W3100488932 cites W4211132630 @default.
• W3100488932 doi "https://doi.org/10.1136/ijgc-2020-001893" @default.
• W3100488932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8431282" @default.
• W3100488932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33177150" @default.
• W3100488932 hasPublicationYear "2020" @default.
• W3100488932 type Work @default.
• W3100488932 sameAs 3100488932 @default.
• W3100488932 citedByCount "10" @default.
• W3100488932 countsByYear W31004889322021 @default.
• W3100488932 countsByYear W31004889322022 @default.
• W3100488932 countsByYear W31004889322023 @default.
• W3100488932 crossrefType "journal-article" @default.
• W3100488932 hasAuthorship W3100488932A5001959447 @default.
• W3100488932 hasAuthorship W3100488932A5002011120 @default.
• W3100488932 hasAuthorship W3100488932A5003962206 @default.
• W3100488932 hasAuthorship W3100488932A5013693581 @default.
• W3100488932 hasAuthorship W3100488932A5014189905 @default.
• W3100488932 hasAuthorship W3100488932A5014743938 @default.
• W3100488932 hasAuthorship W3100488932A5016164818 @default.
• W3100488932 hasAuthorship W3100488932A5016445492 @default.
• W3100488932 hasAuthorship W3100488932A5018811618 @default.
• W3100488932 hasAuthorship W3100488932A5019663026 @default.
• W3100488932 hasAuthorship W3100488932A5040765699 @default.
• W3100488932 hasAuthorship W3100488932A5052359409 @default.
• W3100488932 hasAuthorship W3100488932A5053542215 @default.
• W3100488932 hasAuthorship W3100488932A5055502131 @default.
• W3100488932 hasAuthorship W3100488932A5064259361 @default.
• W3100488932 hasAuthorship W3100488932A5086380204 @default.
• W3100488932 hasBestOaLocation W31004889322 @default.
• W3100488932 hasConcept C121608353 @default.
• W3100488932 hasConcept C126322002 @default.
• W3100488932 hasConcept C143998085 @default.
• W3100488932 hasConcept C146357865 @default.
• W3100488932 hasConcept C151730666 @default.
• W3100488932 hasConcept C2776512503 @default.
• W3100488932 hasConcept C2780849966 @default.
• W3100488932 hasConcept C2781182431 @default.
• W3100488932 hasConcept C29456083 @default.
• W3100488932 hasConcept C71924100 @default.
• W3100488932 hasConcept C86803240 @default.
• W3100488932 hasConceptScore W3100488932C121608353 @default.
• W3100488932 hasConceptScore W3100488932C126322002 @default.
• W3100488932 hasConceptScore W3100488932C143998085 @default.
• W3100488932 hasConceptScore W3100488932C146357865 @default.
• W3100488932 hasConceptScore W3100488932C151730666 @default.
• W3100488932 hasConceptScore W3100488932C2776512503 @default.
• W3100488932 hasConceptScore W3100488932C2780849966 @default.
• W3100488932 hasConceptScore W3100488932C2781182431 @default.
• W3100488932 hasConceptScore W3100488932C29456083 @default.
• W3100488932 hasConceptScore W3100488932C71924100 @default.
• W3100488932 hasConceptScore W3100488932C86803240 @default.
• W3100488932 hasFunder F4320337351 @default.
• W3100488932 hasIssue "2" @default.
• W3100488932 hasLocation W31004889321 @default.
• W3100488932 hasLocation W31004889322 @default.
• W3100488932 hasLocation W31004889323 @default.
• W3100488932 hasOpenAccess W3100488932 @default.
• W3100488932 hasPrimaryLocation W31004889321 @default.
• W3100488932 hasRelatedWork W1964681864 @default.
• W3100488932 hasRelatedWork W2018380129 @default.
• W3100488932 hasRelatedWork W2038032297 @default.
• W3100488932 hasRelatedWork W2055460663 @default.
• W3100488932 hasRelatedWork W2127954959 @default.
• W3100488932 hasRelatedWork W2168086922 @default.
• W3100488932 hasRelatedWork W2362152694 @default.
• W3100488932 hasRelatedWork W2395191958 @default.
• W3100488932 hasRelatedWork W2472792267 @default.
• W3100488932 hasRelatedWork W2567744077 @default.
• W3100488932 hasVolume "31" @default.
• W3100488932 isParatext "false" @default.
• W3100488932 isRetracted "false" @default.

• next